Dominik Meyer
Foot & Ankle Surgery · Valparaiso, INNPI 1932548500
Payments from drug & device makers
Across 109 payments — averaging $28.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$853
- Stryker$671
- Smith+Nephew$617
- AbbVie$299
- Johnson & Johnson$142
- Biotissue Holdings Inc.$87
- plus $406 from 17 others
What the payments were for
- Travel & lodging$70323%
- Food & beverage$2,34676%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 6 | $853 |
| Stryker(2 entities) | 15 | $671 |
| Smith+Nephew | 43 | $617 |
| AbbVie | 14 | $299 |
| Johnson & Johnson | 5 | $142 |
| Biotissue Holdings Inc. | 1 | $87 |
| Orthofix Medical, Inc. | 5 | $75 |
| Kerecis Limited | 2 | $33 |
| Paragon 28, Inc. | 2 | $27 |
| Zimmer Biomet | 2 | $26 |
| Medartis Inc. | 1 | $26 |
| Osteomed LLC | 1 | $25 |
| Amgen | 2 | $25 |
| Abbott | 1 | $23 |
| Organogenesis Inc. | 1 | $23 |
| Medwest Associates | 1 | $20 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Misonix Inc | 1 | $17 |
| Medline Industries LP | 1 | $15 |
| Arthrosurface Incorporated | 1 | $14 |
| Bioventus LLC | 1 | $14 |
| Aroa Biosurgery Incorporated | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,074 in reported general payments places this provider in the 40th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $782 |
| Pregabalin | 17 | $563 |
| Ketoconazole | 17 | $382 |
| Ibuprofen | 34 | $293 |
| Ciclopirox | 15 | $238 |
| Terbinafine Hcl | 17 | $161 |
| Gabapentin | 18 | $134 |
| Cephalexin | 11 | $57 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $57 |
| Tramadol Hcl | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Valparaiso
- Cynthia GrundyValparaiso$23K
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
- Christopher WintersCarmel$158K
- Steven DouthettFort Wayne$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.